We are delighted to invite you to a special event on Scenario Planning that will take place in Zürich @Au Premier, room Les Trouvailles, on the 7th of June, 18:30 onwards.
Dr. Baljit Singh, Managing Director & Partner of Life Sciences at INOVIS AG (and former Director of Global Integrated Insights at Novartis Pharma AG) along with Mika Partanen, Director of Global Competitive Intelligence at Bayer Pharma AG, will provide an overview of a new, unique and first-in-class web-based scenario planning tool – ProACT – which helps mitigate risk, leverage opportunities and optimize strategies.
You will hear first-hand insights and case studies from years of experience from Big Pharma. During this exclusive session, you will hear about the multiple benefits derived from scenario planning and learn how to:
1. Systematically approach scenario planning
2. Leverage and apply fundamental tools utilized during the scenario planning process
3. Prepare your organization for external threats and internal issues
4. Identify opportunities and align YOUR organization for the challenges ahead
5. Prioritize activities, focus areas and initiatives.
In addition, Marc Limacher, Founder and President of INOVIS, will facilitate a fireside chat with additional insights into how scenario planning and primary research create competitive advantage. For this segment we would like to ask and encourage you to bring your own examples to share and discuss.
Please consult our website for more details.
Source: swissintell.org: Reap the Many Benefits of ProACTive Scenario Planning – Mitigate Risk, Leverage Opportunities & Optimize Strategy — swissintell.org SMWP – Schweizerischer Verband für Marktbeobachtung, Wettbewerbsanalyse und Strategieplanung SMCS – Swiss Association for Market Research, Competitive Intelligence and Strategic Planning ASVIE – Association Suisse en Veille Stratégique et Intelligence Economique